Market Research Logo

Generex Biotechnology Corporation - Product Pipeline Review - 2014

45 Pages Global Markets Direct January 31, 2014 SKU: GMD5201738

Generex Biotechnology Corporation - Product Pipeline Review - 2014

Summary

Global Market Direct’s pharmaceuticals report, “Generex Biotechnology Corporation - Product Pipeline Review - 2014” provides data on the Generex Biotechnology Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Generex Biotechnology Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from Generex Biotechnology Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • Generex Biotechnology Corporation - Brief Generex Biotechnology Corporation overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Generex Biotechnology Corporation human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Generex Biotechnology Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Generex Biotechnology Corporation’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Evaluate Generex Biotechnology Corporation’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Generex Biotechnology Corporation in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Generex Biotechnology Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Generex Biotechnology Corporation.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Generex Biotechnology Corporation and identify potential opportunities in those areas.

Show Full Description


Show Table of Contents



Generex Biotechnology Corporation - Product Pipeline Review - 2014

Global Markets Direct
January 31, 2014

Search inside this report



Pricing & Delivery

Online Download
$1,500
Site License
$3,000
Global Site License
$4,500

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report